Advertisements
Prohibited substance cases under FEI anti-doping rules
The FEI has announced two adverse analytical findings involving prohibited substances.
The cases involve the use of Ractopamine, and O-Desmethyltramadol, a metabolite of Tramadol which are *Banned Substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Horse: HSM Cornelio (FEI ID 104GP38/COL)
Person Responsible: Pablo Carreño Mora (FEI ID 10072192 /COL)
Event: CEI1* 80 – Ubate (COL), 19-20.08.2017
Prohibited Substance: Ractopamine
Date of notification (7 November 2017)
Horse: Saura De Fondcombe (FEI ID 103CM83/SUI)
Person Responsible: Nadja Peter Steiner (FEI ID 10006562/SUI)
Event: CSI3*-W – Tetouan (MAR) 05-08.10.2017
Prohibited Substance: O-Desmethyltramadol
Date of notification (9 November 2017)
The athletes listed have been provisionally suspended from the date of notification until the FEI Tribunal renders a decision. The horses, also listed, have been provisionally suspended for two months:
Details on these cases can be found here.
Suzanne Ashton: BA (Hons) in Marketing Management, Diploma in Equine Studies, B.E.M.A Member. An entrepreneur with over a decade of experience in marketing, publishing, content curation, editing, and media writing. Avid equestrian, riding since the age of 5 and owning horses for over 35 years. Proud mum to humans, dogs, and a horse.